Novavax, Inc. (NASDAQ: NVAX) is 242.50% higher on its value in year-to-date trading and has touched a low of $3.53 and a high of $23.86 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NVAX stock was last observed hovering at around $15.12 in the last trading session, with the day’s gains setting it 1.32%.
Currently trading at $16.44, the stock is 24.50% and 23.96% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 14.82 million and changing 8.73% at the moment leaves the stock 126.59% off its SMA200. NVAX registered 89.40% gain for a year compared to 6-month gain of 258.95%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 9.24% loss in the last 1 month and extending the period to 3 months gives it a 299.03%, and is 38.85% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.60% over the week and 7.43% over the month.
Novavax, Inc. (NVAX) has around 1543 employees, a market worth around $2.31B and $996.61M in sales. Profit margin for the company is -40.01%. Distance from 52-week low is 365.41% and -31.10% from its 52-week high.
The EPS is expected to grow by 107.92% this year.
Novavax, Inc. (NVAX) Top Institutional Holders
The shares outstanding are 139.51M, and float is at 133.33M with Short Float at 22.15%.
Novavax, Inc. (NVAX) Insider Activity
The most recent transaction is an insider sale by YOUNG JAMES F,the company’sDirector. SEC filings show that YOUNG JAMES F sold 7,500 shares of the company’s common stock on Jun 21 ’24 at a price of $14.09 per share for a total of $0.11 million. Following the sale, the insider now owns 61760.0 shares.
Novavax, Inc. disclosed in a document filed with the SEC on Jun 18 ’24 that YOUNG JAMES F (Director) sold a total of 7,500 shares of the company’s common stock. The trade occurred on Jun 18 ’24 and was made at $13.72 per share for $0.1 million. Following the transaction, the insider now directly holds 69260.0 shares of the NVAX stock.
Still, SEC filings show that on Jun 17 ’24, Dubovsky Filip (President, R&D) disposed off 13,904 shares at an average price of $14.47 for $0.2 million. The insider now directly holds 66,613 shares of Novavax, Inc. (NVAX).
